Dr. Bernard Le Foll, PhD, MD, MCFP (AM)
Vice-President, Research & Academics / Chief Scientific Officer

Dr. Bernard Le Foll joined the Waypoint Research Institute team in February 2022 as Vice-President of Research and Academics and Chief Scientific Officer. 

Dr. Le Foll is a clinician-scientist specializing in drug addiction. He is the Chair of Addiction Psychiatry at the University of Toronto and is a Professor in the departments of Psychiatry, Family and Community Medicine, Pharmacology and Toxicology, as well as the Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health. Dr. Le Foll has practiced in the area of Addiction Medicine at the Centre for Addiction and Mental Health (CAMH) in Toronto since 2006. His multi-disciplinary research approach seeks to better understand the neurobiology of addiction and develop novel therapeutic strategies. 

Dr. Le Foll leads CAMH’s Translational Addiction Research Laboratory within the Campbell Family Mental Health Research Institute. He obtained his PhD in Pharmacology at University of Paris Sud in France and has performed post-doctoral training in behavioral pharmacology and brain imaging within the intra-mural program of the National Institutes of Health. He has a vast list of achievements and has received many awards and more than 80 grants. Dr. Le Foll has published more than 230 peer-reviewed scientific articles. He has been an advisor for multiple agencies, has developed clinical guidelines, been involved in policy and been invited to speak at the Senate and House of Commons on addiction related issues. 

Keywords: research, behavioural pharmacology, neurobiology, policy.

Research Interests

Behavioural pharmacology and drug addiction; clinical pharmacology; neuropharmacology; psychopharmacology; pharmacogenetics.

Publications

PubMed Publications

Stay Connected

[email protected]

Dr. Bernard Le Foll